We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 203.21%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$1.67B
AUM Growth
+$159M
Cap. Flow
+$11.7M
Cap. Flow %
0.7%
Top 10 Hldgs %
44.6%
Holding
84
New
7
Increased
30
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$24.9M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$17.7M
3
ATEC icon
Alphatec Holdings
ATEC
+$15.5M
4
INSM icon
Insmed
INSM
+$12.9M
5
RLAY icon
Relay Therapeutics
RLAY
+$12.9M

Top Sells

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$31.4M
2
CDNA icon
CareDx
CDNA
+$25.2M
3
BTAI
BioXcel Therapeutics
BTAI
+$15.5M
4
MRVI icon
Maravai LifeSciences
MRVI
+$11.2M
5
HCAT icon
Health Catalyst
HCAT
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 94.7%
2 Communication Services 4.44%
3 Miscellaneous 0.67%
4 Energy 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
76
Pfizer
PFE
$157B
$332K 0.02%
8,469
– –
UHS icon
77
Universal Health Services
UHS
$10.4B
$300K 0.02%
2,050
– –
EBS icon
78
Emergent Biosolutions
EBS
$326M
$270K 0.02%
4,294
– –
MCK icon
79
McKesson
MCK
$105B
$257K 0.02%
1,346
– –
BTAI
80
DELISTED
BioXcel Therapeutics
BTAI
– –
-22,402
Closed -$15.5M
JAZZ icon
81
Jazz Pharmaceuticals
JAZZ
$15.6B
– –
-53,484
Closed -$8.79M
MASS icon
82
908 Devices
MASS
$412M
– –
-20,700
Closed -$1M
QTRX icon
83
Quanterix
QTRX
$129M
– –
-27,100
Closed -$1.58M
ZYME icon
84
Zymeworks
ZYME
$1.86B
– –
-117,848
Closed -$3.72M
1 2 3
4

Similar funds

AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.65B AUM 18.1% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

First Light Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, First Light Asset Management held 84 positions worth $1.67B, up 11% from $1.51B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

First Light Asset Management's Q2 2021 filing shows 7 new, 30 increased, 18 reduced and 5 closed positions. Its largest new stake was Relay Therapeutics: 390,555 shares worth $14.3M. The largest sale was Prothena Corp, an estimated $31.4M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 95% a quarter earlier, followed by Communication Services and Miscellaneous.

  • First Light Asset Management's largest Q2 2021 buy was Relay Therapeutics: 390,555 shares worth $14.3M.
  • First Light Asset Management added most to Turning Point Therapeutics, Inc. Common Stock in Q2 2021, an estimated $24.9M increase.
  • First Light Asset Management's biggest Q2 2021 reduction was Prothena Corp, cutting an estimated $31.4M.
  • First Light Asset Management fully exited BioXcel Therapeutics in Q2 2021, selling an estimated $15.5M.
  • First Light Asset Management's ten largest holdings make up 45% of its $1.67B portfolio in Q2 2021.
  • First Light Asset Management opened 7 new positions and closed 5 in Q2 2021.
  • First Light Asset Management's portfolio value rose 11% quarter-over-quarter to $1.67B.

Based on First Light Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.